Pepcid 10 mg Norge - norsk - Statens legemiddelverk

pepcid 10 mg

mcneil sweden ab - famotidin - tablett, filmdrasjert - 10 mg

Fampridine Accord Den europeiske union - norsk - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - multippel sklerose - andre nervesystemet narkotika - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Amifampridine SERB Den europeiske union - norsk - EMA (European Medicines Agency)

amifampridine serb

serb sa - amifampridine phosphate - lambert-eaton myasthenic syndrome; paraneoplastic syndromes, nervous system; nervous system neoplasms; paraneoplastic syndromes; nervous system diseases; autoimmune diseases of the nervous system; neurodegenerative diseases; neuromuscular diseases; neuromuscular junction diseases; immune system diseases; autoimmune diseases; autoimmune diseases of the nervous system; cancer; neoplasms - andre nervesystemet narkotika - symptomatisk behandling av lambert-eaton myasthenisk syndrom (lems) hos voksne.

Fampridine Sandoz 10 mg Norge - norsk - Statens legemiddelverk

fampridine sandoz 10 mg

sandoz a/s - fampridin - depottablett - 10 mg

Pepcidduo Norge - norsk - Statens legemiddelverk

pepcidduo

mcneil sweden ab - famotidin / magnesiumhydroksid / kalsiumkarbonat - tyggetablett med spearmintsmak - 10 mg / 165 mg / 800 mg

Firdapse (previously Zenas) Den europeiske union - norsk - EMA (European Medicines Agency)

firdapse (previously zenas)

serb sa - amifampridine - lambert-eaton myasthenisk syndrom - andre nervesystemet narkotika - symptomatisk behandling av lambert-eaton myasthenisk syndrom (lems) hos voksne.

Fampyra Den europeiske union - norsk - EMA (European Medicines Agency)

fampyra

biogen netherlands b.v.  - fampridine - multippel sklerose - andre nervesystemet narkotika - fampyra angis for forbedring av gåing i voksen pasienter med multippel sklerose innen funksjonshemming (utvidet funksjonshemming status skala 4-7).

Stelfonta Den europeiske union - norsk - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - hunder - for behandling av ikke-resectable, ikke-metastatisk (som staging) subkutan mast celle svulster som ligger på eller distalt for albue eller hock, og ikke-resectable, ikke metastatisk kutan mast celle svulster i hunder.

Lumykras Den europeiske union - norsk - EMA (European Medicines Agency)

lumykras

amgen europe bv - sotorasib - karsinom, ikke-småcellet lunge - antineoplastiske midler - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Vafseo Den europeiske union - norsk - EMA (European Medicines Agency)

vafseo

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemiske preparater - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.